MetLife Investment Management, LLC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 70 filers reported holding KALA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$128,379
-8.9%
18,935
+0.8%
0.00%
-50.0%
Q3 2020$140,918
-28.6%
18,7890.0%0.00%0.0%
Q2 2020$197,472
+83.9%
18,789
+53.8%
0.00%0.0%
Q1 2020$107,361
-9.8%
12,214
+62.6%
0.00%
+100.0%
Q1 2018$119,0007,5110.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders